Targeting cancer stem cells via dendritic-cell vaccination

OncoImmunology

Volumn 1, Issue 8, 2012, Pages 1401-1403

  Teitz Tennenbaum, Seagal ^a   Wicha, Max S ^a   Chang, Alfred E ^b   Li, Qiao ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cancer stem cells; Dendritic cell vaccines; Immunotherapy

Indexed keywords

ALDEHYDE DEHYDROGENASE; CANCER VACCINE; DENDRITIC CELL VACCINE; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER STEM CELL; CELLULAR IMMUNITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; EXPERIMENTAL MOUSE; HUMORAL IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; INOCULATION; MELANOMA; MOLECULAR MECHANICS; NONHUMAN; NOTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPLEEN CELL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TARGET CELL; TUMOR IMMUNITY; TUMOR XENOGRAFT;

EID: 84886945658     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21026     Document Type: Note

References (10)

1. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, et al. Identification of cells initiating human melanomas. Nature 2008; 451:345-9; PMID:18202660; http://dx.doi.org/10.1038/nature06489.
2. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466:133-7; PMID:20596026; http://dx.doi.org/10.1038/nature09161.
3. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104:973-8; PMID:17210912; http://dx.doi.org/10.1073/pnas.0610117104.
4. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8:755-68; PMID:18784658; http://dx.doi.org/10.1038/nrc2499.
5. Shafee N, Smith CR, Wei S, Kim Y, Mills GB, Hortobagyi GN, et al. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Cancer Res 2008; 68:3243-50; PMID:18451150; http://dx.doi.org/10.1158/0008-5472.CAN-07-5480.
6. Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M, et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 2010; 120:485-97; PMID:20051626; http://dx.doi.org/10.1172/JCI39397.
7. Ning N, Pan Q, Zheng F, Teitz-Tennenbaum S, Egenti M, Yet J, et al. Cancer stem cell vaccination confers significant antitumor immunity. Cancer Res 2012; 72:1853-64; PMID:22473314; http://dx.doi.org/10.1158/0008-5472.CAN-11-1400.
8. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1:555-67; PMID:18371393; http://dx.doi.org/10.1016/j.stem.2007.08.014.
9. Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; 32:1195-201; PMID:20073073; http://dx.doi.org/10.1002/hed.21315.
10. Visus C, Wang Y, Lozano-Leon A, Ferris RL, Silver S, Szczepanski MJ, et al. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8+ T cells. Clin Cancer Res 2011; 17:6174-84; PMID:21856769; http://dx.doi.org/10.1158/1078-0432.CCR-11-1111.